Effective Jan. 1, 2012, Regence Blue Shield in Washington updated their Individual plans to include 3 benefit enhancements required by federal and state law (President Obama’s HealthCare Reform Bill).
To cover the added costs associated with the enhanced benefits, premiums for Individuals on the Regence Evolve Plus and Regence Evolve HSA 100 Plan increased on April 1, 2012.
The increase ranged between 0% and 2% depending upon the policy. There was no rate change for the Regence Evolve Core or Regence Evolve HSA Plans.
What were the 3 benefit enhancements that were added January 1st?
- · Removal of Annual Dollar Limits on Prescriptions
Specific dollar limits on Rx benefits have been removed from the Evolve Plus and HSA 100 plans. These plans formerly had the following annual dollar limits: $2,500 (Plus) and $2,000 (HSA 100). - · Self-administered chemotherapy covered at level comparable to provider-administered chemotherapy
With the passage of House Bill 1517, the Washington Legislature mandated that plans providing coverage for cancer chemotherapy treatment must also provide coverage for prescribed, self-administered anti-cancer medication on a basis that’s at least comparable to cancer chemotherapy medications administered by a physician or hospital. They modified Individual products to comply with this legislation - Rx deductible waived for diabetic insulin and supplies
For new and existing Regence Evolve Plus plans, Regence now waives the prescription medication deductible on brand-name medications for insulin and diabetic supplies. This change, which arose out of discussion with the OIC, addresses a concern regarding benefit designs that may discriminate against those with conditions for which a generic drug is not available, especially diabetes.

